The U.S. Food and Drug Administration (FDA) recently announced that the risks of narcotic painkiller Opana are greater than its potential benefits for patients. The FDA is urging the maker of Opana, Endo Pharmaceuticals, to take the product from the market. The main concern of the FDA is the potential for abuse and addiction and […]

Testosterone replacement therapy has been controversial for years, but now new trial information is adding another risk to the use of the synthetic hormone supplement. A National Institutes of Health (NIH)-funded trial recently reported that men using AndroGel, a testosterone gel, had more dangerous plaque buildup in their arteries than men receiving a placebo. More […]